Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,129.20
(
0.47%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
101.26
(
3.01%
)
Bitcoin
74,422.18
(
-0.56%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 63355

Tuesday, 06/10/2008 5:41:44 PM

Tuesday, June 10, 2008 5:41:44 PM

Post# of 257253
Re: Generic Copaxone

Mylan’s CEO, Robert Coury, is IMO a loose cannon. It would not surprise me if MYL’s Copaxone PR turned out to be a bluff for the benefit of Wall Street––i.e. a diversion from MYL’s self-inflicted balance-sheet woes.

It’s worth noting that MYL’s PR contained no mention of the financial terms between MYL and NATCO. Regards, Dew

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now